Fundz

Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer - PharmiWeb.com

TAKEN PRIVATEOct 03, 2023

Position

Chief Executive Officer

Company

Kezar Life Sciences

Christopher Kirk
ckirk@kezarbio.com
CaliforniaBiotechnologyHealth CareTherapeuticsBiopharma

Description

John Fowler will be resigning from his role as Chief Executive Officer effective November 7, 2023, and Christopher Kirk, Ph.D. has been appointed as Chief Executive Officer. Dr

Quick answer

Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer - PharmiWeb.com (October 3, 2023). Kezar Life Sciences is based in California, United States.

Who is the new Chief Executive Officer at Kezar Life Sciences?
Kezar Life Sciences named Christopher Kirk Chief Executive Officer, announced October 3, 2023.
What did Kezar Life Sciences announce on October 3, 2023?
John Fowler will be resigning from his role as Chief Executive Officer effective November 7, 2023, and Christopher Kirk, Ph.D. has been appointed as Chief Executive Officer.
What does Kezar Life Sciences do?
Kezar Life Sciences is a clinical-stage biopharmaceutical company discovering and developing novel treatments for immune-mediated and oncologic disorders.
Where is Kezar Life Sciences based?
Kezar Life Sciences is based in California, United States.
Which similar companies made leadership changes around the same time?
AnHeart Therapeutics (September 28, 2023), Pfizer (September 28, 2023), Royalty Pharma plc (September 21, 2023) and Summit Therapeutics (October 16, 2023) also announced leadership changes within 45 days of Kezar Life Sciences.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Kezar Life Sciences, and when

A new leader at Kezar Life Sciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kezar Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kezar Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kezar Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kezar Life Sciences

Location

California, United States

About

Kezar Life Sciences is a clinical-stage biopharmaceutical company discovering and developing novel treatments for immune-mediated and oncologic disorders. The company is pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function to inhibit multiple drivers of disease via single, powerful targets. Zetomipzomib, its lead development asset, is a selective immunoproteasome inhibitor that has completed a Phase 2 clinical trial in lupus nephritis. This product candidate also has the potential to address multiple chronic immune-mediated diseases. KZR-261 is the first anti-cancer clinical candidate from the company’s platform targeting the Sec61 translocon and the protein secretion pathway. An open-label, dose-escalation Phase 1 clinical trial of KZR-261 to assess safety, tolerability and preliminary tumor activity in solid tumors is underway. For more information, visit www.kezarlifesciences.com, and follow us on LinkedIn, Facebook, Twitter and Instagram.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kezar Life Sciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Christopher
Likely contact at this company
••••••••@••••••••

See Christopher's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kezar Life Sciences's next move

Learn about Strategic plan

Kezar Life Sciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.